Incorporate the most advanced diagnostic methods and interventions into your daily practice thanks to this program, with which you will be able to deepen your knowledge of issues such as targeted therapy with radioligands"

The disciplines of radiology and Nuclear Medicine have undergone major transformations in recent years, allowing the specialist to incorporate surgical techniques and diagnostic methods of great precision. Thus, these fields are two of the most advanced in medicine today, so the professional who wishes to keep up to date has to take an update program like this Advanced master’s degree in Nuclear Medicine and Radiodiagnostics.

This degree has been designed with the aim of offering physicians the most recent developments in these areas, so that they can integrate into their daily work the latest innovations in issues such as the treatment of cerebral vasospasm, the combined technique of BSGC and localization of occult lesion (SNOLL), teragnosis applied to neuroendocrine and gastroenteropancreatic tumors or breast cancer screening and the BI-RADS system, among many others.

All this, from a 100% online learning system that will adapt to the personal circumstances of the specialist, since they will be able to decide when, where and how to study, without having to submit to rigid schedules and without uncomfortable trips to an academic center. In addition, a teaching staff of great international prestige will accompany you throughout the entire process and will use numerous multimedia resources to make the program's educational itinerary more effective.

This program is developed in a 100% online format and will allow you to combine your work with your studies, without submitting to rigid schedules or requiring you to travel to an academic center" 

This Advanced master’s degree in Nuclear Medicine and Radiodiagnostics contains the most complete and up-to-date scientific program on the market. The most important features include:

• Development of practical cases presented by experts in Nuclear Advanced master’s degree
• The graphic, schematic, and eminently practical contents with which they are created, provide scientific and practical information on the disciplines that are essential for professional practice
• Practical exercises where self-assessment can be used to improve learning
• Special emphasis on innovative methodologies in Nuclear Medicine and Radiodiagnostics
• Theoretical lessons, questions to the expert, debate forums on controversial topics, and individual reflection assignments
• Content that is accessible from any fixed or portable device with an Internet connection

Get updated thanks to the prestigious teaching staff selected by TECH, composed of working professionals who know all the latest developments in these specialized fields" 

Its teaching staff includes professionals belonging to the field of medicine, who bring to this program the experience of their work, in addition to recognized specialists from prestigious reference societies and universities.

The multimedia content, developed with the latest educational technology, will provide the professional with situated and contextual learning, i.e., a simulated environment that will provide an immersive training experience designed to train for real-life situations.

This program is designed around Problem-Based Learning, whereby the student must try to solve the different professional practice situations that arise during the academic year. For this purpose, the professional will be assisted by an innovative interactive video system created by renowned and experienced experts.

You will learn about the latest advances in Nuclear Medicine applied to pediatrics, deepening in PET/PET-CT/PET-MRI techniques in pediatric and young adult patients"

The best multimedia materials are waiting for you: Video proceedings, interactive summaries, case studies, master classes"

This Advanced master’s degree in Nuclear Medicine and Radiodiagnostics has a structure of 34 specialized modules, through which the physician will be able to delve into the most recent innovations in aspects such as the management of neuroendocrine tumors using molecular techniques, radiopharmaceuticals for positron emission tomography, the treatment of intracerebral AVMs in radiology or selective internal radiation therapy (SIRT), among many others.

The most up-to-date contents in the application of Nuclear Medicine in the different tumors can be found in this program" 

Module 1. Management

1.1. Strategic Planning

1.1.1. Benefits  
1.1.2. Vision, Mission and Values of the Health Care Institution and the Nuclear Medicine Unit  
1.1.3. Models: SWOT Analysis  

1.2. Organization and Management  

1.2.1. Organizational and Functional Structure  
1.2.2. Technical Equipment  
1.2.3. Human resources  

1.3. Information Systems  

1.3.1. Indicators and Indices

1.4. Knowledge Management  
1.5. Quality Program

1.5.1. ISO Standard  
1.5.2. Clinical Audits  
1.5.3. Objectives of Clinical Audits  
1.5.4. The Audit Cycle  
1.5.5. Evidence Based Medicine  
1.5.6. Elements of Quality: Structure, Process and Outcomes  

1.6. Economic Evaluation of Nuclear Medicine Processes
1.7. Adequacy of Imaging Tests  

1.7.1. What Should Be Done?  
1.7.2. What Not to Do?  

1.8. Risk Management 

1.8.1. Levels of Responsibility 
1.8.2. Patient Security

1.9. Teleworking in Nuclear Medicine 

1.9.1. Technical Needs  
1.9.2. Legislation: Employment Relationship, Data Protection Act 

Module 2. Radiomics 

2.1. Artificial Intelligence, Machine Learning, Deep Learning

2.2. Radiomics Today  
2.3. Imaging Biomarkers   
2.4. Multidimensionality in the Image  
2.5. Applications: Diagnosis, Prognosis and Prediction of Response  
2.6. Evidence Levels  
2.7. Combination with Other "Omics": Radiogenomics 

Module 3. Single Photon Emission Nuclear Medicine: “pearls and pitfalls” 

3.1. Pneumology 

3.1.1. Perfusion/Ventilation 
3.1.2. Pulmonary Thromboembolism 
3.1.3. Pulmonary Hypertension 
3.1.4. Lung Transplant 
3.1.5. Pleuroperitoneal Fistula: Cirrhotic Patient, Peritoneal Dialysis 

3.2. Cardiology 

3.2.1. Perfusion: Ischemic Heart Disease, Cell Viability, Cell Contribution  
3.2.2. GATED, Myocarditis 
3.2.3. Shunt: Left-Right, Right-Left 
3.2.4. Ventricular Function: Ischemic Heart Disease, Cardiotoxicity 
3.2.5. Cardiac Innervation: Cardiac Pathology, Neurological Pathology 

3.3. Vascular and Lymphatic System 

3.3.1. Peripheral Endothelial Function 
3.3.2. Lower Limb Perfusion 
3.3.3. Lymphoscintigraphy 

3.4. Osteoarticular 

3.4.1. Primary Benign and Malignant Tumor Pathology: Planar Imaging 
3.4.2. Hybrid Image Contribution 
3.4.3. Bone Metastases: Contributions of SPECT and SPECT/CT, Usefulness in Diagnosis and Follow-up
3.4.4. Benign Pathology: Metabolic Disease, Sports Pathology 

3.5. Nephrourology 

3.5.1. Assessment of Renal Malformations 
3.5.2. Obstructive Pathology: Hydronephrosis in Pediatric Age: Diagnosis and Follow-up, Adult Hydronephrosis, Study in Urinary Shunts 
3.5.3. Pyelonephritis: Initial Diagnosis, Evolution 
3.5.4. Renal Transplantation: Rejection, Tubular Necrosis, Nephrotixicity, Urinary Leakage 
3.5.5. Vasculorenal Hypertension: Diagnosis and Follow-up 
3.5.6. Glomerular Filtration and Effective Renal Plasma Flow 
3.5.7. Cystogammagraphy: Direct and Indirect in the Diagnosis and Follow-Up of Vesicoureteral Reflux 

3.6. Gastroenterology 

3.6.1. Salivary Glands: Autoimmune Pathology, Post-radiation Damage, Salivary Gland Tumors 
3.6.2. Digestive Transit: Esophageal Transit, Gastroesophageal Reflux, Pulmonary Aspiration, Gastric Emptying 
3.6.3. Gastrointestinal Bleeding: Study with Labeled Red Blood Cells, Study with Radiocolloids 
3.6.4. Hepatobiliary Pathology: Aliasic Cholecystitis, Hepatic Functional Reserve Assessment, Hepatic Transplantation (Rejection, Biliary Leakage), Biliary Tract Atresia 
3.6.5. Bile Acid Malabsorption  
3.6.6. Inflammatory Bowel Disease: Diagnosis, Follow-up and Complications  
3.6.7. Hepatic Space-Occupying Lesion: Hepatic Hemangioma, Focal Nodular Hyperplasia Vs. Adenoma 
3.6.8. Cell Labeling: Method and Indications 
3.6.9. Red Blood Cells: In Vivo, In Vitro, In Vivitro 
3.6.10. Leukocytes 

3.7. Splenic Pathology 

3.7.1. Space-Occupying Lesions: Hemangioma, Hamartoma  
3.7.2. Splenosis: Study with Denatured Labeled Red Cells 
3.7.3. Cellular Kidnapping 

3.8. Endocrinology  

3.8.1. Thyroid: Thyroid Hyperfunction (Autoimmune, Thyroiditis), Thyroid Nodule, Differentiated Thyroid Carcinoma 
3.8.2. Parathyroid: Hyperfunctioning Gland Location  
3.8.3. Adrenal Glands: Adrenal Cortex Pathology (Hypercortisolism, Hyperaldosteronism), Adrenal Medulla Pathology (Hyperplasia, Pheochromocytoma), Adrenal Incidental Adrenal Incidentaloma 

3.9. Neurology SPECT Vs. PET:

3.9.1. Cognitive Impairment: Characteristic Patterns and Differential Diagnosis  
3.9.2. Movement Disorders: Parkinson's Disease, Parkinson's Plus and Differential Diagnosis  
3.9.3. Epilepsy: Pre-surgical Assessment, Acquisition Protocols  

3.10. Oncology: Tumor Viability, Radionecrosis Vs. Progression 

3.10.1. Brain Death 
3.10.2. Cerebrospinal Fluid (CSF)-Cysternogammography Kinetics: Hydrocephalus, CSF Leakage 

Module 4. Infection/Inflammation: Gammagraphic Studies and PET Tracers 

4.1. Osteoarticular 

4.1.1. Osteomyelitis: Previously Healthy Bone, Diabetic Patient, Spine Surgery 
4.1.2. Prosthesis: Septic Mobilization Vs. Aseptic 

4.2. Cardiac  

4.2.1. Endocarditis - Native Valve, Prosthetic Valve 
4.2.2. Myocarditis: Infectious Vs. Inflammatory 
4.2.3. Intracardiac Devices 

4.3. Vascular 

4.3.1. Inflammatory Vasculitis 
4.3.2. Prosthetic Graft Infection 

4.4. Encephalitis: PET-FDG Study 

4.4.1. Paraneoplastic 
4.4.2. Infectious: Patterns and Differential Diagnosis

4.5. Fever of Unknown Origin 

4.5.1. Immunosuppressed Patients
4.5.2. Postoperative Fever and Recurrent Sepsis 

4.6. Systemic Disease 

4.6.1. Sarcoidosis: Diagnosis, Extent and Response to Treatment  
4.6.2. Ig4-Related Disease 

4.7. Other Localizations 

4.7.1. Hepatorenal Polycystic Kidney Disease: Localization of the Infectious Focus 
4.7.2. Hepatobiliary: Post-surgical Patient 

4.8. Covid-19

4.8.1. Nuclear Medicine Studies in Acute Phase: Pulmonary Inflammation, Pulmonary Thromboembolism, Oncology Patient and COVID-19
4.8.2. Utility of Nuclear Medicine in Post-covid Pathology: Pulmonary, Systemic 
4.8.3. Organizational Changes in a Pandemic Situation 

Module 5. Nuclear Medicine in Pediatrics    

5.1. Pediatric MN 

5.1.1. Management of the Child in Nuclear Medicine: Information to Parents and/or Guardians, Preparation and Scheduling, Appropriate Environments 
5.1.2. Dose Optimization 
5.1.3. Sedation and Anaesthesia 
5.1.4. Physical Aspects in Pediatric Patients: Image Acquisition and Processing 

5.2. PET/PET-CT/PET-MRI in Pediatric and Young Adult Patients 

5.2.1. Protocol Optimization 
5.2.2. Indications  
5.2.3. Non-FDG Tracers 

5.3. Central Nervous System/LCR 

5.3.1. Brain Maturation Patterns 
5.3.2. Epilepsy and Vascular Disorders 
5.3.3. Brain Tumors 
5.3.4. Hydrocephalus and Cerebrospinal Fluid Fistula

5.4. Endocrine 

5.4.1. Thyroid Pathology: Hypothyroidism, Hyperthyroidism, Thyroid Nodule 
5.4.2. Hyperinsulinism 

5.5. Cardiopulmonary 

5.5.1. Congenital Heart Disease: Right-to-Left Shunt , Left-to-Right Shunt  
5.5.2. Bronchopulmonary Pathology: Congenital and Acquired 

5.6. Gastrointestinal System

5.6.1. Dynamic Esophagogastric Studies 
5.6.2. Gastroesophageal Reflux, Bronchopulmonary Aspiration 
5.6.3. Hepatobiliary Scintigraphy: Biliary Tract Atresia 
5.6.4. Intestinal Bleeding: Mekel's Diverticulum, Intestinal Duplication 

5.7. Nephrourology 

5.7.1. Hydronephrosis Evaluation 
5.7.2. Renal Cortical Assessment: In Infections, Ectopias, etc 
5.7.3. Vesicoureteral Reflux: Diagnosis and Follow-up 
5.7.4. Others: Renal Malformations, Renal Transplantation, Kidney Transplantation 

5.8. Osteoarticular System 

5.8.1. Benign Lesions in Pediatric Patients: Fractures, Tumors, etc. 
5.8.2. Avascular Necrosis: Perthes' Disease and Others 
5.8.3. Sympathetic Reflex Sympathetic Dystrophy 
5.8.4. Low Back Pain 
5.8.5. Infection: Osteomyelitis, Spondylodiscitis 

5.9. Neuroblastoma  

5.9.1. Diagnostic Studies: Bone Scintigraphy, MIBG and Other PET Radiotracers 
5.9.2. Radiometabolic Treatment: MIBG, 177Lu-DOTATATE 

5.10. Other tumours 

5.10.1. Osteosarcoma: Diagnosis, Response Assessment and Follow-Up 
5.10.2. Bone Tracers and 18F-FDG-PET/CT PET/CT Study 
5.10.3. Ewing's Disease: Diagnosis, Response Assessment and Follow-up 
5.10.4. Bone Tracers and 18F-FDG-PET/TC Studies 
5.10.5. Lymphoma: 18F-FDG PET/CT in Diagnosis, Response Assessment, Follow-up 
5.10.6. Rhabdomyosarcoma and Soft Tissue Sarcoma: 18F-FDG PET/CT in Diagnosis, Response Assessment and Follow-up 

Module 6. Neuroendocrine Tumors 

6.1. Causes and Risk Factors 

6.1.1. Hereditary Syndromes 

6.2. Clinical Presentation

6.2.1. Signs 
6.2.2. Symptoms: Endocrine Syndromes 

6.3. Anatomopathological Diagnosis  

6.3.1. Degrees of Cellular Differentiation 
6.3.2. Classification 

6.4. Subtypes and Localizations 

6.4.1. Extrapancreatic 
6.4.2. Pancreatic 

6.5. Staging  

6.5.1. Endoscopic Techniques 
6.5.2. Imaging Techniques 
6.5.3. Echo, CT, MRI 

6.6. Molecular Techniques 

6.6.1. 111In, 99mTc, 8Ga-Labeled Somatostatin Analogues 
6.6.2. Advantages and Disadvantages of Each of Them Best Choice Based on Availability 
6.6.3. 18F-FDG: Contributions to Patient Management 
6.6.4. Combined FDG-Somatostatin Analogues Studies 
6.6.5. Other Targets  

6.7. Treatment  

6.7.1. Available Treatments 
6.7.2. Radiometabolic Therapy: When and How 

6.8. Evaluation of Response to Treatment 

6.8.1. Clinical - Biochemistry 
6.8.2. Morphological 
6.8.3. Functional Criteria 

6.9. Monitoring  

6.9.1. Clinical-Biochemistry 
6.9.2. Image: Morphological and Functional The Best Sequence 

6.10. Clinical Trials 

6.10.1. Sequencing of Therapies 
6.10.2. Association: Combined Treatments 

Module 7. Radio-Guided Surgery 

7.1. Sentinel Node Selective Biopsy (SNBGS) 

7.1.1. Detection with Radiopharmaceuticals and Combined Techniques 

7.1.1.1. Radiocolloids, Dyes 
7.1.1.2. BSGC Breast Cancer 

7.1.2. Initial Staging 
7.1.3. In Neoadjuvant  

7.2. BSGC Gynecological Tumors 

7.2.1. Vulva 
7.2.2. Cervix  
7.2.3. Endometrium 
7.2.4. Ovaries 

7.3. BSGC Skin Cancer 

7.3.1. Melanoma 
7.3.2. Non-melanoma

7.4. BSGC Head and Neck Tumors 

7.4.1. Thyroid Cancer 
7.4.2. Oral Cavity 

7.5. BSGC Gastrointestinal Tumors 

7.5.1. Oesophageal Cancer 
7.5.2. Stomach Cancer 
7.5.3. Colorectal Carcinoma 

7.6. BSGC Urological Cancers 

7.6.1. Penis 
7.6.2. Prostate 

7.7. Combined Technique of BSGC and Occult Lesion Localization (SNOLL) 

7.7.1. Breast  
7.7.2. Other Localizations 

7.8. ROLL 

7.8.1. Radiopharmaceuticals 99mTc, Seeds 125-I 
7.8.2. Indications: Tumor Pathology and Other Applications 

7.9. Radio-Guided Surgery in Primary Hyperparathyroidism 

7.9.1. Indications 
7.9.2. Protocols According to Radiopharmaceuticals 

Module 8. PET/CT- PET/MRI in Oncology Clinical Guidelines 

8.1. Nuclear Medicine in Different Tumors 

8.1.1. Staging and Prognosis 
8.1.2. Response to Treatment  
8.1.3. Follow-up and Diagnosis of Recurrence 

8.2. Lymphomas 

8.2.1. Hodgkin Lymphoma 
8.2.2. Diffuse Large B-cell Lymphoma 
8.2.3. Other Lymphomas

8.3. Breast Cancer 

8.3.1. Initial Staging 
8.3.2. Response to Neoadjuvant Therapy 
8.3.3. Monitoring 

8.4. Gynecological Tumors 

8.4.1. Vagina Cervix: Staging, Response to Treatment and Follow-up 
8.4.2. Endometrium: Staging, Response to Treatment and Follow-up 
8.4.3. Ovary: Staging, Response to Treatment and Follow-up 

8.5. Lung Cancer 

8.5.1. Non-small Cell Carcinoma of the Lung 
8.5.2. Small Cell Carcinoma of the Lung 
8.5.3. Response Assessment: Radiation Therapy, Immunotherapy 

8.6. Digestive Tumors  

8.6.1. Esophago-Gastric  
8.6.2. Colorectal  
8.6.3. Pancreas 
8.6.4. Hepatobiliary: Hepatocarcinoma, Cholangiocarcinoma 

8.7. Sarcomas 

8.7.1. Bone 
8.7.2. Soft Parts 

8.8. Urogenitals  

8.8.1. Prostate 
8.8.2. Renal  
8.8.3. Bladder 
8.8.4. Testicle 

8.9. Endocrine 

8.9.1. Thyroid 
8.9.2. Adrenal  

8.10. Radiotherapy Planning 

8.10.1. Acquisition of Scanning 
8.10.2. Volume Delimitation 

Module 9. Targeted Therapy with Radioligands 

9.1. Theragnosis 

9.1.1. Clinical and Therapeutic Implications 

9.2. Thyroid 

9.2.1. Hyperthyroidism 
9.2.2. Differentiated Thyroid Carcinoma 
9.2.3. Goiter 

9.3. Neuroendocrine, Gastroenteropancreatic and Other Tumors: Radiolabeled Peptides

9.3.1. Indications 
9.3.2. Administration

9.4. Pheochromocytoma and Paragangliomas: 131I-MIBG 

9.4.1. Indications and Patient Selection 
9.4.2. Administration Protocols 
9.4.3. Results  

9.5. Bone Metastases  

9.5.1. Pathophysiology of Bone Metastases 
9.5.2. Basis of Radiometabolic Therapy 
9.5.3. Radiopharmaceuticals Used: Indications and Results 

9.6. Selective Internal Radiation Therapy (SIRT): Labeled Microspheres

9.6.1. Basis of Therapy with Radio-Labeled Microspheres 
9.6.2. Available Devices: Differential Characteristics 
9.6.3. Calculation of the Activity to Be Administered and Dosimetric Evaluation According to the Device 
9.6.4. Hepatocarcinoma: Application and Results  
9.6.5. Liver Metastases: Application and Results in Colorectal Carcinoma, Neuroendocrine and Other Tumors 
9.6.6. Contributions of SIRT to Liver Surgery 
9.6.7. Potentially Resectable Patient 
9.6.8. Hepatic Lobe Hypertrophy 

9.7. Synoviorthesis  

9.7.1. Pathophysiological Basis of Treatment 
9.7.2. Radiopharmaceuticals Used 
9.7.3. Indications and Clinical Experience in Different Locations and Pathologies: Rheumatoid Arthritis, Other Arthritis, Vellonodular Synovitis 
9.7.4. Applications in Pediatrics: Hemophilic Patient 

9.8. Metastatic Prostate Cancer: 177Lu-PSMA  

9.8.1. Pathophysiological Bases 
9.8.2. Patient Selection 
9.8.3. Management Protocols and Results

9.9. Lymphomas: Radioimmunotherapy 

9.9.1. Pathophysiological Bases 
9.9.2. Indications 
9.9.3. Administration Protocols 

9.10. Future

9.10.1. Search for New Ligands and Radioisotopes 
9.10.2. Translational Research  
9.10.3. Lines of Research 

Module 10. Nuclear Medicine

10.1. Physical Bases of Ionizing Radiation 

10.1.1. Ionizing Radiation and Radioactive Isotopes 
10.1.2. Types of Radiation 

10.2. Biological Effects of Ionizing Radiations 

10.2.1. Classification of Effects According to: Time of Occurrence 
10.2.2. Biological and Dose Dependent Effect 
10.2.3. Interaction of Ionizing Radiation with Matter 
10.2.4. Ionizing Radiation-Cell Interaction: Characteristics, Direct and Non-direct Effects 
10.2.5. Radiosensitivity 
10.2.6. Adaptive Response 

10.3. Radiopharmaceuticals 

10.3.1. The Radiopharmaceutical 
10.3.2. Conventional Diagnostic Radiopharmaceuticals 
10.3.3. Radionuclide Generators 
10.3.4. Localization Mechanisms 
10.3.5. Positron Emission Tomography Radiopharmaceuticals 
10.3.6. Synthesis Scheme 
10.3.7. Metabolic Pathway Substrates 
10.3.8. Radiopharmaceuticals with Therapeutic Effect 

10.3.8.1. Characteristics that Must Be Met 
10.3.8.2. Design and Approval 

10.4. Radiopharmacy 

10.4.1. Regulatory Framework  
10.4.2. Operation 
10.4.3. Quality Control  

10.5. Image Acquisition and Processing 

10.5.1. Planar Image 
10.5.2. Components 
10.5.3. Performance: Resolution and Sensitivity 
10.5.4. Acquisition Modes: Static, Dynamic, Synchronized 
10.5.5. Reconstruction 
10.5.6. Single Photon Tomography (SPECT) 
10.5.7. Acquisition 
10.5.8. Reconstruction 
10.5.9. Positron Emission Tomography (PET) 
10.5.10. Components
10.5.11. Data Acquisition 
10.5.12. Operating Parameters 

10.6. Quantification Techniques: Basis 

10.6.1. In Cardiology 
10.6.2. In Neurology 
10.6.3. Metabolic Parameters 
10.6.4. The Image of TC 

10.7. Image Generation 

10.7.1. Acquisition and Reconstruction Parameters 
10.7.2. Protocols and Contrast Media 
10.7.3. Head and Neck 
10.7.4. Chest: Cardiology, Pulmonary 
10.7.5. Abdomen: General, Liver, Renal 

10.8. The Image of RM 

10.8.1. Resonance Phenomenon 
10.8.2. Tissue Contrast: Sequence Knowledge 
10.8.3. Diffusion 
10.8.4. Paramagnetic Contrasts 

10.9. The Multimodality Image  

10.9.1. SPECT/TC 
10.9.2. PET/TC 
10.9.3. PET/RM 

10.10. Radioprotection 

10.10.1. Radioprotection 
10.10.2. Special situations: Pediatric, Pregnancy and Lactation 
10.10.3. Regulatory Framework: Implementation  
10.10.4. Dosimetry

Module 11. Neuroradiology

11.1. Cerebrovascular Disease
11.2. TBI.
11.3. Demyelinating Diseases
11.4. Dementia and Neurodegenerative Diseases
11.5. Basic Aspects of Cerebral Malformations. Hydrocephalus
11.6. Infections
11.7. Study of the Pituitary Gland
11.8. Spinal Cord Injuries
11.9. Central Nervous System Tumors
11.10. Monitoring and Assessment in Response to Supratentorial CNS Tumors
11.11. Advanced Techniques in Neuroradiology (Diffusion, Perfusion, Spectroscopy)

Module 12. Sensory Organ

12.1. Ophthalmologic Pathology
12.2. Study of the Base of the Skull
12.3. Naso-Sinus Pathology
12.4. Neoplasms of the Oral Cavity, Larynx and Pharynx (ORL)

Module 13. Chest

13.1. Airspace Pathology
13.2. Pleural Pathology
13.3. ILD (Diffuse Interstitial Lung Diseases)
13.4. COPD (Acute Chronic Obstructive Pulmonary Disease)
13.5. Infections
13.6. Lung Cancer

13.6.1. Diagnosis and Staging
13.6.2. Monitoring and Response Assessment

13.7. Mediastinal Tumors
13.8. Vascular Pathology
13.9. Thoracic Trauma
13.10. Heart

13.10.1. Cardiac CT
13.10.2. Cardiac MRI
13.10.3. Management of Ischemic Heart Disease
13.10.4. Myocardiopathies
13.10.5. Valvulopathies
13.10.6. Congenital Diseases
13.10.7. Tumours

Module 14. Abdomen

14.1. Iodinated, Gadolinium (Gd)-based and Enteral Contrast Agents
14.2. Liver

14.2.1. Focal Liver Lesion
14.2.2. Diffuse Liver Disease
14.2.3. Management of Cirrhosis Liver
14.2.4. Study and Pathology of the Biliary Route

14.3. Pancreas.

14.3.1. Pancreatitis
14.3.2. Pancreatic Cancer

14.4. Splenic Lesions
14.5. Inflammatory Bowel Disease
14.6. Peritoneal Carcinomatosis
14.7. Staging and Response Assessment in Rectal Cancer
14.8. Technique and Indications of CT Colonoscopy
14.9. Defecography: Technique and Indications
14.10. Urology

14.10.1. Renal, Ureteral and Bladder Cancer
14.10.2. Multiparametric Study of Prostate Cancer. PI-RADS
14.10.3. Testicular Cancer

Module 15. Musculoskeletal System (MSK)

15.1. Rotator Cuff Pathology
15.2. Glenohumeral Instability
15.3. Degenerative Wrist Pathology
15.4. Degenerative Wrist Trauma
15.5. Degenerative Spine Pathology
15.6. Meniscal Pathology
15.7. Knee Ligament Pathology
15.8. Cartilage and Knee Arthropathy
15.9. Ankle Trauma Lesions
15.10. Muscle-Tendinous Injuries

Module 16. Breast

16.1. Advances in Breast Imaging Techniques
16.2. Breast Cancer Screening and Bi-RADS System
16.3. FNA and Breast BAG
16.4. Breast Cancer Staging
16.5. Monitoring and Response Assessment in Breast Cancer

Module 17. Gynecology

17.1. Radiology of the Benign Pathology of the Uterus and Adnexa
17.2. Staging in Uterine and Cervical Cancer
17.3. Imaging Techniques in Ovarian Cancer

Module 18. Management in Radiology

18.1. Radiology Services Management
18.2. PACS (Picture Archiving and Communications System). RIS (Radiological Information Systems). Teleradiology
18.3. Radiological Report
18.4. Medical-Legal Aspects in Radiology

Module 19. Basis of Intervention Procedures

19.1.    Radiological Protection in Interventional Procedures
19.2.    Arterial and Venous Puncture for Interventional Access Seldinger and Trocar Technique
19.3.    Ultrasound Puncture for Vascular Access
19.4.    Compression of Puncture Sites and Care 

Module 20. Materials in Interventional Techniques

20.1. Materials in Neurointerventionism
20.2. Materials in Vascular Interventional Techniques
20.3. Materials in Oncologic Interventional Techniques
20.4. Materials in Musculoskeletal Interventional Techniques
20.5. Materials for Drainage and Non-vascular Interventional Procedures

Module 21. Venous and Lymphatic Interventional Procedures

21.1. Phlebography of the Upper and Lower Limbs. Cavography
21.2. Superior Vena Cava Syndrome
21.3. Pulmonary Embolism and Deep Vein Thrombosis
21.4. Central Roads, Port a Cath, PICS
21.5. Diagnostic and Therapeutic Lymphography
21.6. Inferior Vena Cava Filter Placement
21.7. Dialysis Catheter Placement, Replacement and Removal
21.8. Angioplasty and Thrombectomy of Vascular Access for Dialysis
21.9. Transjugular Liver Biopsy, Hepatic Hemodynamic Study and Hepatic Venous Sampling
21.10. Treatment of Venous Insufficiency in Lower Limbs

Module 22. Vascular Diagnosis

22.1. Abdominal Aortography and Arteriography of Lower Limbs
22.2. Arteriography of Visceral Digestive Trunks

Module 23. Vascular Therapy

23.1. Peripheral Vascular Angiopathy and Stents
23.2. Arterial Thrombolysis of Lower Limbs and Percutaneous Thrombectomy
23.3. Percutaneous Vascular Closures
23.4. ATP of Renal Arteries and Stent
23.5. ATP and Stenting of Visceral Digestive Trunks
23.6. Aneurysms in Visceral Arteries. Diagnosis and Treatment
23.7. Aortic Aneurysms. Endoprosthesis
23.8. Treatment of Diabetic Foot

Module 24. Embolotherapy

24.1. Upper and Lower Gastrointestinal Bleeding
24.2. Renal Embolization
24.3. Embolization in Trauma
24.4. Prostatic Embolization
24.5. Uterine Embolization
24.6. Portal Embolization
24.7. Hepatic Chemoembolization
24.8. Hepatic DEBIRI

Module 25. Diagnostic Punctures

25.1. Image-Guided Percutaneous Biopsy. FNA
25.2. Renal Biopsy
25.3. Hepatic Biopsy
25.4. Pulmonary Biopsy

Module 26. Diagnostic Neurointerventionism

26.1. Cerebral Arteriography
26.2. Spinal Arteriography
26.3. Petrosal Sinus Sampling
26.4. Wada Test

Module 27. Therapeutic Neurointerventionism

27.1. Embolization of Cerebral Aneurysms
27.2. Treatment of Cerebral Vasospasm
27.3. Carotid Stent, Vertebral Stent and Cerebral Stent
27.4. Endovascular Treatment of an Ischemic Stroke
27.5. Embolization in Epistaxis
27.6. Embolization of Cerebral Meningiomas and Paragangliomas
27.7. Treatment of Intracerebral AVMs
27.8. Dural Fistulas, Diagnosis and Treatment
27.9. Spinal Vascular Malformations

Module 28. Musculoskeletal Interventionism

28.1. Discography
28.2. Vertebroplasty, Vesselplasty and Kyphoplasty
28.3. Infiltration and Facet Rhizolysis
28.4. Percutaneous Discectomy
28.5. Epidurolisis and Pain Management
28.6. Percutaneous Ganglionic Block for Pain
28.7. Joint Infiltrations

Module 29. Urologic Interventionism

29.1. Percutaneous Nephrostomy
29.2. Anterograde Double J 
29.3. Retrograde Double J and Endourological Interventionism
29.4. Ureteral and Urethral Endoprosthesis

Module 30. Thoracic Interventionism

30.1. Thoracentesis, Thoracic Drainage and Associated Techniques
30.2. Drainage of Thoracic Abscesses

Module 31. Puncture Drainage

31.1. Biliary Drainage
31.2. Drainage of Abscesses. Approaches and Technique
31.3. Percutaneous Gastrostomy and Gastrojejunostomy
31.4. Percutaneous Cholecystostomy

Module 32. Ablative techniques

32.1. Tumor Ablation with Radiofrequency and Microwaves
32.2. Tumor Cryoablation Irreversible Electroporation

Module 33. Other Aspects of Interest in Interventional Radiology

33.1. Extraction of Foreign Bodies
33.2. Multimodality Fusion
33.3. Nanoparticles. Future of Interventional Radiology

Module 34. Management and Organization in Image-Guided Therapy

34.1. Informed Consent in Interventional Radiology
34.2. The Outpatient Clinic and the Interventional Radiology Department
34.3. Anaesthesia in Interventional Radiology

34.3.1. Local Anesthetics
34.3.2. Sedation and Analgesia
34.3.3. Nerve Blocker

34.4. Medical Management Protocols in General and Interventional Radiology
34.5. Medication Used in Neurointerventionism
34.6. Medication Used in Vascular and Non-Vascular Interventionism
34.7. Management in Interventional Radiology: RVUs, DRGs, Indicators
34.8. Intervention Rooms

Enjoy the most updated knowledge in Nuclear Medicine and Radiodiagnostics presented in multimedia format by the leading specialists in these areas at international level"